BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34529288)

  • 21. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.
    Tay J; Masini G; McEniery CM; Giussani DA; Shaw CJ; Wilkinson IB; Bennett PR; Lees CC
    Am J Obstet Gynecol; 2019 Jan; 220(1):96.e1-96.e8. PubMed ID: 30243605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction.
    Melchiorre K; Leslie K; Prefumo F; Bhide A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2009 May; 33(5):524-9. PubMed ID: 19382287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal cardiac deceleration capacity: a novel insight into maternal autonomic function in pregnancies complicated by hypertensive disorders and intrauterine growth restriction.
    Casati D; Stampalija T; Ferrazzi E; Alberti AM; Scebba I; Paganelli A; Di Martino D; Muggiasca ML; Bauer A
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():6-11. PubMed ID: 27612213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction.
    Roberts LA; Ling HZ; Poon LC; Nicolaides KH; Kametas NA
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):507-514. PubMed ID: 29607557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population.
    Hafner E; Metzenbauer M; Höfinger D; Stonek F; Schuchter K; Waldhör T; Philipp K
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):652-7. PubMed ID: 16514618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
    Tan MY; Poon LC; Rolnik DL; Syngelaki A; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):52-59. PubMed ID: 29704277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Lolos M; Anampousi K; Mamalis M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin delays the onset of hypertensive disorders of pregnancy among nulliparous pregnant women: A secondary analysis of the ASPIRIN trial.
    Kavi A; Hoffman MK; Somannavar MS; Metgud MC; Goudar SS; Moore J; Nielsen E; Goco N; McClure EM; Lokangaka A; Tshefu A; Bauserman M; Mwenechanya M; Chomba E; Carlo WA; Figueroa L; Krebs NF; Jessani S; Saleem S; Goldenberg RL; Das P; Patel A; Hibberd PL; Esamai F; Bucher S; Koso-Thomas M; Silver R; Derman RJ
    BJOG; 2023 Nov; 130 Suppl 3(Suppl 3):16-25. PubMed ID: 37470099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of birth weight on fetal cardiac indices at 35-37 weeks' gestation.
    Semmler J; Abdel-Azim S; Anzoategui S; Zhang H; Nicolaides KH; Charakida M
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):266-272. PubMed ID: 33094501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates.
    Zhang B; Chen X; Yang C; Shi H; Xiu W
    Hypertens Pregnancy; 2024 Dec; 43(1):2314576. PubMed ID: 38375828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine artery Doppler evaluation in twin pregnancies at 11 + 0 to 13 + 6 weeks of gestation.
    Rizzo G; Pietrolucci ME; Aiello E; Capponi A; Arduini D
    Ultrasound Obstet Gynecol; 2014 Nov; 44(5):557-61. PubMed ID: 24585633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of small-for-gestational-age neonates: screening by fetal biometry at 19-24 weeks.
    Lesmes C; Gallo DM; Panaiotova J; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):198-207. PubMed ID: 25704207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-trimester contingent screening for small-for-gestational-age neonate.
    Nowacka U; Papastefanou I; Bouariu A; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):177-184. PubMed ID: 34214232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-modality and in-vivo validation of 4D flow MRI evaluation of uterine artery blood flow in human pregnancy.
    Hwuang E; Wu PH; Rodriguez-Soto A; Langham M; Wehrli FW; Vidorreta M; Moon B; Kochar K; Parameshwaran S; Koelper N; Tisdall MD; Detre JA; Witschey W; Schwartz N
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):722-731. PubMed ID: 32898295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between reduced fetal movements at term and abnormal uterine artery Doppler indices.
    Pagani G; D'Antonio F; Khalil A; Akolekar R; Papageorghiou A; Bhide A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2014 May; 43(5):548-52. PubMed ID: 24123633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.